These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, June 11, 2013. They include Lululemon, Apple and Disney.
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Friday, May 24, 2013. They include Cubist Pharmaceuticals, Marvell Technology and Procter & Gamble.
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that…
Stocks are down midday Monday, with the Dow Jones Industrial Average down 0.30%, the Nasdaq down 0.22% and the S&P 500 down 0.15%. Today’s big winners are two pharmaceutical companies, with one getting…
247sam When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech sector this…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. AECOM Technology Corporation (NYSE: ACM) Cut to Underperform at BofA/ML. Alnylam Pharmaceuticals,…
The three major US stock indexes opened slightly higher this morning, but the DJIA almost immediately turned south and remained in negative territory all session. The Nasdaq composite and S&P 500 turned…
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) took a rather sharp beating yesterday on word that it was going to have a secondary offering. We now have details on that offering and it comes…
Jon C. Ogg Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) may have interrupted its rally with a proposed offering of 7 million shares of common stock, but it least did this when shares were close to highs…
Jon C. Ogg Biotech is about to become even less of a diversified sector due to mergers and acquisitions. Genzyme Corporation (NASDAQ: GENZ) and Cephalon Inc. (NASDAQ: CEPH) will end up accounting for about $30…
Here are some of the top stories affecting key drug and biotech stocks this Friday. We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec Inc. (Nasdaq:…
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals Inc.’s (NASDAQ:…
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com: Cigna corp. (NYSE: CI), Aetna Inc. (NYSE: AET), and other managed care…
Alnylam (Nasdaq: ALNY) leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to rise. BioHealth Investor began by analyzing 171 stocks in the biotech sector…
These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street research calls early this Wednesday morning: Alnylam (ALNY) Started as Buy at Jefferies…
